Bryan Johnson: I Just Took the Most Powerful Dose of DMT in the World... Here's What It Was Like
Episode Details
In an episode of the All-In Podcast, supported by Eight Sleep, host David Friedberg interviews Bryan Johnson about his extensive Longevity protocols. Johnson details his use of 5-MeO-DMT, a compound significantly more potent than DMT. Unlike traditional longevity interventions such as Rapamycin, Metformin, Hyperbaric oxygen therapy, and the Sauna, psychedelics like Psilocybin and 5-MeO-DMT profoundly impact the brain. They dissolve the Default mode network, which drives Neuroplasticity and can reduce systemic Inflammation. Johnson also observed positive shifts in his Microbiome and Blood glucose levels. To measure these changes, he used Kernel, his neurotech company that previously studied Ketamine for treating Depression. Using MRI and EEG, Kernel tracked his brain's activity. However, Johnson acknowledges the risks, noting that high-dose psychedelics could induce Psychosis or trigger Schizophrenia. The conversation then explores the future of human enhancement, touching on brain-computer interfaces like Neuralink and the broader implications of AI. Johnson outlines his next steps in Cell and Gene Therapy, including Mitochondrial rejuvenation to potentially treat Parkinson's and Alzheimer's. He also discusses delivering the FOXO3 Gene via Mesenchymal stem cells for massive Tissue regeneration. Furthermore, Johnson is growing personalized Organoids from Induced Pluripotent Stem Cells, created using Yamanaka factors. Because overdosing Yamanaka factors carries a severe risk of Cancer, they theorize that future therapies will require Cellular switches for precise control. They highlight companies like New Limit, founded by Blake Byers and Brian Armstrong, which are pioneering this space. Friedberg suggests that using AI as a project manager will vastly accelerate these biological discoveries. Finally, they discuss macro-level technological shifts, comparing these biological advancements to Fusion Energy. They predict that GLP-1s will be the first major step in solving Obesity and Metabolic disorder. By addressing these physical ailments and the widespread Mental Health crisis, they believe American Society will enter an era of unprecedented Abundance. Ultimately, this state of prosperity and well-being is viewed as the most effective way to counter the societal temptation toward Socialism.
The episode explores the intersection of extreme longevity protocols, neuro-enhancement, and biological engineering. It highlights the use of high-dose psychedelics for neuroplasticity and the potential for advanced genetic therapies like mitochondrial rejuvenation and cellular reprogramming to combat metabolic and age-related decline.
Portfolio lens: A high-conviction, long-term venture and biotech watchlist focused on radical human enhancement and biological rejuvenation.
Generated with gemini-3.1-flash-lite on 7/19/2026, 5:42:18 AM. For research only. Not financial advice.Psychedelic-Assisted Neuro-Rejuvenation
High-dose psychedelics may function as a potent longevity intervention by inducing neuroplasticity and dampening the default mode network to restore youthful cognitive patterns.
The episode suggests that psychedelics like 5-MeO-DMT and psilocybin can act as a 'metabolic reset' for the brain, potentially reversing age-related cognitive narrowing and systemic inflammation.
- Bryan Johnson observed a 'childlike' state and improved blood glucose levels following high-dose psychedelic administration.
- Kernel neurotech data showed a dampening of the default mode network and emergent new brain connectivity patterns post-psilocybin.
- Psychedelics are being positioned as a tool for 'psychological rejuvenation' to maintain a 'can-do' attitude in aging adults.
- Increased clinical trial data quantifying the physiological effects of psychedelics on biomarkers.
- Regulatory shifts allowing for controlled, high-fidelity administration of these compounds.
- Potential for permanent psychosis or triggering latent mental health conditions like schizophrenia.
- Unpredictable behavioral shifts that could impact professional and personal responsibilities.
- Lack of standardized, safe, and legal frameworks for high-dose administration.
- Review clinical literature on the long-term impact of 5-MeO-DMT on the default mode network.
- Analyze the safety protocols and regulatory status of psychedelic-assisted therapy providers.
Next-Generation Cellular Reprogramming
The future of regenerative medicine lies in precise cellular control through synthetic switches and gene therapy, moving beyond simple Yamanaka factor expression.
The episode identifies the primary risk of current reprogramming (cancer/overdosing) and highlights the need for 'cellular switches' to precisely regulate protein synthesis in vivo.
- New Limit is highlighted as a company using computational discovery to accelerate cellular reprogramming.
- Mitochondrial rejuvenation via red blood cell envelope delivery is identified as a high-potential therapeutic modality.
- The use of FOXO3 gene delivery via mesenchymal stem cells is cited as a breakthrough for tissue regeneration.
- Development of reliable, synthetic cellular switches for gene expression control.
- Successful replication of mitochondrial rejuvenation in human clinical trials.
- Integration of AI-driven project management to accelerate biological discovery pipelines.
- High risk of oncogenesis if reprogramming factors are not perfectly dosed.
- Complexity of delivering gene therapies to specific tissues without systemic side effects.
- Long development timelines for cell and gene therapy platforms.
- Investigate the current state of 'cellular switch' technology in synthetic biology.
- Monitor the progress of companies focused on mitochondrial augmentation and FOXO3 delivery.
Watchlist
- New Limit
- Kernel
- GLP-1 receptor agonists
- Mitochondrial rejuvenation clinical trials
- Synthetic biology cellular switch startups
Open Questions
- What is the decay curve of the 'reset' effect provided by high-dose psychedelics?
- Can cellular switches be engineered to provide a fail-safe against oncogenic transformation in reprogramming?
- How do we reconcile the potential for radical personality shifts with the need for long-term personal and professional stability?
Key Topics & People
Host of the All-In Podcast conducting the interview with Ryan Cohen.
The podcast hosting the interview with GameStop CEO Ryan Cohen.
Co-founder of Coinbase and co-founder of New Limit.
Investor and co-founder of the life sciences company New Limit.
A sleep technology company that sponsors the podcast.
A psychedelic compound shown to dampen the default mode network and drive neuroplasticity.
A medical treatment involving breathing pure oxygen in a pressurized environment, used for longevity.
A brain network associated with ego and rumination that becomes rigid with age and is suppressed by psychedelics.
Blood sugar levels that experienced a profound metabolic reset after psychedelic therapy.
The brain's ability to rewire itself and form new neural connections, stimulated by psychedelics.
A biological response targeted by longevity therapies because it drives aging and disease.
A developing therapy aimed at restoring the energy-producing function of cells using young donor mitochondria.
A mental disorder that could be triggered in predisposed individuals by psychedelics.
A progressive neurodegenerative disease targeted by new mitochondrial therapies.
A neurodegenerative disorder that could potentially be treated by mitochondrial therapy.
Multipotent stem cells used as a delivery mechanism for gene therapies like FOXO3.
Adult cells genetically reprogrammed to an embryonic stem cell-like state for creating organoids.
Theoretical biological mechanisms to control the dosing of Yamanaka factors to prevent cancer.
The process of renewal and growth to repair tissue, a key goal of FOXO3 therapies.
Health conditions affecting metabolism, reported to affect a massive portion of the population.
The strategic use of artificial intelligence to direct and accelerate complex biological research.
The general populace of the US, currently experiencing high rates of poor health and unhappiness.
A widespread societal issue exacerbated by poor physical health and digital distraction.
A powerful future energy technology, ranked as highly impactful but currently behind AI and longevity therapies.
Protein transcription factors used to induce cells to become pluripotent stem cells.
A gene associated with longevity and massive tissue regeneration.
Advanced medical treatments modifying genes or using cells to rejuvenate the body.
A mental health disorder that ketamine and other therapies aim to treat.
The community of microorganisms in the body, which was altered positively by psilocybin use.
Entrepreneur known for his intensive Blueprint protocol and longevity experiments.